Commentary on the OPTINIV Trial

icTV interview with John Laffey

In this video, John Laffey discusses the strengths and challenges related to the OPTINIV trial on the effect of postoperative high-flow nasal cannula vs conventional oxygen therapy on hypoxemia in patients after major abdominal surgery. The results of this clinical trial were presented at LIVES 2016 in Milan and have been recently published in Intensive Care Medicine. 

Read the article in ICM:

Jaber, S., Monnin, M., Girard, M. et al. Apnoeic oxygenation via high-flow nasal cannula oxygen combined with non-invasive ventilation preoxygenation for intubation in hypoxaemic patients in the intensive care unit: the single-centre, blinded, randomised controlled OPTINIV trial. Intensive Care Med 42, 1877–1887 (2016). https://doi.org/10.1007/s00134-016-4588-9